Clinical associates

Pulmonary Fibrosis Foundation Expands Care Center Network for PF Patients

Retrieved on: 
Thursday, October 12, 2023
Diagnosis, Urgent care center, ILD, Inflammation, PF, Nursing, PFF, University, Pulmonary fibrosis, Clinical associates, Academic Medical Center (Amsterdam), Scar, Lung, CCN, San Diego, Patient, University of New Mexico, University of California, San Diego, Atmosphere

CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced that seven medical centers have joined the PFF Care Center Network (CCN) as Clinical Associate members, a new membership option. Each of these Clinical Associates will collaborate with an existing Care Center Network site to help bring the resources of the PFF to even more people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD). The Care Center Network includes 81 CCN sites and seven Clinical Associates in 39 states.

Key Points: 
  • CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced that seven medical centers have joined the PFF Care Center Network (CCN) as Clinical Associate members, a new membership option.
  • Each of these Clinical Associates will collaborate with an existing Care Center Network site to help bring the resources of the PFF to even more people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD).
  • The newly designated Clinical Associate members of the PFF Care Center Network are:
    Chest Medicine Associates Center for Interstitial Lung Disease (South Portland, ME): Dr. Meagan Moore, Center Director
    Ochsner LSU Health Shreveport – Academic Medical Center (Shreveport, LA): Dr. Prangthip Charoenpong, Center Director
    University of New Mexico (Albuquerque, NM): Dr. Nour Ass'ad, Center Director
    Through the CCN, Care Centers and Clinical Associates collaborate to promote and provide quality care to those living with PF.
  • Each Clinical Associate is paired with a current Care Center member so they may collaborate to expand and improve pulmonary fibrosis care.

ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor

Retrieved on: 
Wednesday, August 23, 2023
Columbia University, Talimogene laherparepvec, Clinical associates, Merkel-cell carcinoma, Immunotherapy, Associate, Rutgers University, Harvard Medical School, Journal, Rush University, Translational medicine, Patient, Compass, China Bio-Immunity Corporation, Hospital, FDA, Massachusetts General Hospital, Therapy, Roswell Park Comprehensive Cancer Center, Book, Dean (education), Pharmaceutical industry, Cancer, Research

SHENZHEN, China, Aug. 22, 2023 /PRNewswire/ -- ImmVira announced to appoint Dr. Howard L. Kaufman as Consulting Medical Advisor.

Key Points: 
  • SHENZHEN, China, Aug. 22, 2023 /PRNewswire/ -- ImmVira announced to appoint Dr. Howard L. Kaufman as Consulting Medical Advisor.
  • Dr. Kaufman is a leading authority on tumor immunotherapy and oncolytic virus.
  • "We are honored to have Dr. Kaufman as our Consulting Medical Advisor, to jointly explore clinical mechanisms and translational medicine of oncolytic virus, and provide professional advice for our future clinical development.
  • said Dr. Guoying Zhou, Chairman and CEO of ImmVira, "His insights will help us accelerate global clinical progress of oncolytic virus pipelines and meet medical needs of cancer patients as soon as possible."

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Retrieved on: 
Monday, July 17, 2023
Memorial University of Newfoundland, Medical Affairs Bureau, Commercialization, Specialization, University, Royal college, Chronic kidney disease, Clinical associates, Physician, Framingham Heart Study, Department of Medicine – University of Pamplona, Health, Medicine, BD (company), Boston University, Business administration, Nephrology, Royal College of Physicians and Surgeons of Canada, Patient, Internal medicine, Baxter International, Surgeon, CVS Health, CKD, Medication, Kellogg School of Management, Pharmaceutical industry, Nursing, MD, Northwestern University

WINSTON-SALEM, N.C., July 17, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization. Dr. Culleton, who will report to Chief Executive Officer Tim Bertram, joins ProKidney after more than two decades in industry and academia with a primary focus on kidney health.

Key Points: 
  • WINSTON-SALEM, N.C., July 17, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization.
  • Tim Bertram, Chief Executive Officer of ProKidney, said: “I am thrilled to welcome Bruce to the ProKidney team.
  • Before joining CVS Health, he was Vice President, Global Clinical Development and World Wide Vice President, Medical Affairs, Medication and Procedural Solutions at Becton Dickinson; and previously Vice President, Renal Therapeutic Area at Baxter Healthcare.
  • Dr. Culleton added, “With Phase 3 clinical development well underway and initial interim data expected in late 2024, ProKidney is rapidly approaching an important inflection point.

ASDS Opens Registration for Its Highly Rated “Advanced Injection Techniques” Course

Retrieved on: 
Tuesday, June 6, 2023
University, Q&A, Louisiana State University, Clinical associates, Anatomy, ASDS, Skin, MBA, Tulane University, Laser, Medical director, Art, Patient safety, AMA, Faculty, FRCPC, Society, Safety, New York University Grossman School of Medicine, Veterinary medicine, Dentistry, Nursing, Dermatology, MD

The invited course faculty includes:

Key Points: 
  • The invited course faculty includes:
    Vince Bertucci, MD, FRCPC – Dr. Bertucci is the current ASDS President.
  • Deirdre Hooper, MD – Dr. Hooper is a board certified dermatologist and serves on the ASDS Board of Directors.
  • Joely Kaufman, MD – Dr. Kaufman is a board certified dermatologist at Skin Associates of South Florida and Skin Research Institute in Coral Gables.
  • Registration is $979 for ASDS residents and members and $1,279 for non-member dermatologists.

Health at Scale Awarded Patent for Breakthrough AI Technology for Smart Hyper-Personalized Provider Navigation

Retrieved on: 
Wednesday, February 8, 2023
Patent, Health, Scale, Patient, Computer science, University, National Institutes of Health Stroke Scale, Associate, Stanford University School of Medicine, SAN, Machine learning, Clinical associates, Pharmaceutical industry, Nursing

SAN JOSE, Calif., Feb. 8, 2023 /PRNewswire/ -- Health at Scale, the market leader in smart AI-powered technologies to optimize care management, announced today that it has been awarded a patent by the U.S. Patent and Trademark Office for its breakthrough advances in personalized patient-provider matching using machine learning.

Key Points: 
  • Health at Scale's patented technology transforms provider search by empowering patients to find optimal primary and specialist care provider matches specific to their unique individualized health conditions and needs.
  • This patent advances Health at Scale's mission to re-invent care delivery as a precise and personalized process that is deeply aware of each patient's unique health characteristics and circumstances at all times.
  • By rethinking the patient-provider matching process, Health at Scale drives improved outcomes, costs, satisfaction, quality and equity, while reducing unnecessary waste and cost in the system.
  • "Putting each patient's needs at the center of care management is a core element of our work at Health at Scale.

Aidéo Technologies™ Adds to Revenue Cycle and Coding Expertise with Addition of Marcia Leighton

Retrieved on: 
Tuesday, January 17, 2023
HFMA, Chapter, Revenue cycle management, Firstsource, Knowledge, Clinical associates, BEACH, PALM, Gemini, RCM, Building Codes Assistance Project, Management

PALM BEACH GARDENS, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Aidéo Technologies – a leader in AI-enabled automation technology for the healthcare industry – announced today the addition of Revenue Cycle Management (RCM) Executive Marcia Leighton.

Key Points: 
  • PALM BEACH GARDENS, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Aidéo Technologies – a leader in AI-enabled automation technology for the healthcare industry – announced today the addition of Revenue Cycle Management (RCM) Executive Marcia Leighton.
  • “The addition of Marcia Leighton is a significant piece of the puzzle as we continue to grow our team and expertise in revenue cycle management and autonomous coding,” said David Shelton, CEO of Aidéo Technologies.
  • Her past experience includes a most recent stint with MC3 Consulting, revenue cycle leader for multi-specialty provider Clinical Associates, and as Executive Director Client Services for Firstsource.
  • Aidéo provides autonomous coding to the revenue cycle management industry through its Gemini™ system, which includes the Gemini Coding Platform™, Gemini Autonomous Coding Factory™ and Coding Assist service.

Deborah L. Dallam, MD, FAPA, is recognized by Continental Who's Who

Retrieved on: 
Friday, September 9, 2022
Health system, Disease, American, Ageing, Parent, BPS Barbara Wilson Lifetime Achievement Award, Meharry Medical College, FAPA, List of lifetime achievement awards, Dementia, National Medical Association, Community mental health service, Alpha Kappa Alpha, Texas Tech University, Continental, MedStar Montgomery Medical Center, Multimedia, Education, NAACP, Veteran, Geriatric psychiatry, Spelman College, Parkinson's disease, Gardening, Private practice, Loving Memory, University, American Board of Psychiatry and Neurology, Clinical associates, Student, Mentorship, American Psychiatric Association, Raphael, American Board of Commissioners for Foreign Missions, Department, ABPN, Lists of diseases, ALS, Institute, Trauma, Medicine, Patient, Fellowship (medicine), MD, Neurology, Psychiatry

With 39 years in the Medical field, Dr. Deborah L. Dallam has dedicated her Psychiatry career to treating veterans and geriatric patients.

Key Points: 
  • With 39 years in the Medical field, Dr. Deborah L. Dallam has dedicated her Psychiatry career to treating veterans and geriatric patients.
  • Dr. Dallam started her college education with a Bachelor of Science degree in Pre-Med Biology, graduating cum laude from Spelman College.
  • She next attended Meharry Medical College and graduated as a Legacy Graduate with her Medical degree in 1982.
  • Dr. Dallam is board-certified in Psychiatry and Geriatric Psychiatry by the American Board of Psychiatry and Neurology.

Global Health Leader and Physician, Dr. Seema Gupta Joins GATC Health Advisory Board

Retrieved on: 
Thursday, May 19, 2022
Department, Risk, Health, Education, Company, Global Health, Medicine, Marshall University, Cocaine, Preventive healthcare, Multimedia, Science, Clinical associates, Joan C. Edwards School of Medicine, View, Government, Artificial intelligence, Research, GATC, Opioid, Methamphetamine, Brain, PTSD, Time, Internal medicine, Editorial board, Post-traumatic stress disorder, Technology, Public health, Joan, Therapy, Coronavirus Scientific Advisory Board (Turkey), Private practice, Addiction, Human body, Drug discovery, Limbic system, Pharmaceutical industry

Dr. Gupta is a primary care physician with a federal government agency and has specific expertise in Internal Medicine, Preventive Medicine, Public Health, Global Health and Women/LGBT Health.

Key Points: 
  • Dr. Gupta is a primary care physician with a federal government agency and has specific expertise in Internal Medicine, Preventive Medicine, Public Health, Global Health and Women/LGBT Health.
  • Additionally, she serves on the Editorial Board of Internal Medicine Alerts, a leading scientific publication supporting evidence-based decision-making for medical providers.
  • "Dr. Gupta brings a broad range of expertise to GATC Health's Scientific Advisory Board," stated Dr Jonathan Lakey, Chief of the company's science advisory board.
  • "My goal is to bring to GATC Health the unique perspective of a practicing physician with years of experience," explained Dr. Gupta.

Bruce W. Peters, DO, is recognized by Continental Who's Who

Retrieved on: 
Friday, May 13, 2022
Fellow, Philadelphia College of Osteopathic Medicine, American Academy of Facial Plastic and Reconstructive Surgery, Medicine, Director, Multimedia, Patient, Clinical associates, View, Hearing loss, Parent, Albright, University, Thomas Jefferson University, Adult, Kansas City Chiefs, Otorhinolaryngology, DO, Albright College, American Board of Commissioners for Foreign Missions, Board, American Academy of Otolaryngology–Head and Neck Surgery, American Board of Otolaryngology, Medical degree, Nose, Head, Community Medical Center, Private practice, Osteopathic medicine in the United States, Ear, Continental, Medical device, Dentistry, Biology

Board-certified in Otolaryngology-Head and Neck Surgery, Dr. Peters additionally holds a sub-specialty in Facial Plastics and Reconstructive Surgery.

Key Points: 
  • Board-certified in Otolaryngology-Head and Neck Surgery, Dr. Peters additionally holds a sub-specialty in Facial Plastics and Reconstructive Surgery.
  • Also known as ear, nose, and throat doctors, otolaryngologists specialize in head and neck disorders ranging from hearing loss to head and neck cancer.
  • In his practice, Dr. Peters provides care to adult patients with ear, nose, and throat disorders and those with facial cosmetic and reconstructive concerns.
  • Dr. Peters is board certified in Otolaryngology-Head and Neck Surgery through the American Board and Otolaryngology Head and Neck Surgery.

DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities

Retrieved on: 
Wednesday, February 16, 2022
NYSE, Patient, Peritoneal dialysis, Quality of life, American Board of Internal Medicine, Mortality, Clinical associates, DaVita Inc., University School, Beth Israel Deaconess Medical Center, CMO, Dialysis, Nephrology, American Board of Commissioners for Foreign Missions, Kidney disease, Hypertension, Internal medicine, Physician, Harvard Medical School, LSU School of Music, DVA, Louisiana State University School of Medicine, Medical imaging, Medical device, Hospital, Medicine

DENVER, Feb. 16, 2022 /PRNewswire/ -- DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities.

Key Points: 
  • DENVER, Feb. 16, 2022 /PRNewswire/ -- DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities.
  • "Dr. Naljayan is a relentless innovator with a bold vision for at-home kidney care, including helping to increase equitable access to home dialysis for our patients," said Dr. Jeff Giullian, CMO for DaVita Kidney Care.
  • DaVita (NYSE: DVA) is a comprehensive kidney care provider focused on transforming care to improve the quality of life for patients globally.
  • DaVita has reduced hospitalizations, improved mortality and worked collaboratively to propel the kidney care community to adopt an equitable, high-quality standard of care for all patients, everywhere.